Inactive Instrument

SEM4 HLDG

SMFR

US18978W1099

Cm Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021

May 24, 2021 at 02:15 pm

CM Life Sciences, Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced operating loss was USD 1.845 million. Net loss was USD 58.471 million.

Latest news about SEM4 HLDG

SEM4 HLDG : Cowen Initiates Sema4 Holdings at Outperform Rating With $13 Price Target	30/09/21	MT
SEM4 HLDG : Jefferies Starts Sema4 Holdings at Buy with $13 Price Target	24/09/21	MT
Twist Bioscience : SomaLogic Form Partnership to Discover Novel Therapeutic Targets, Antibodies	18/08/21	MT
Sector Update: Health Care Stocks Rising This Afternoon	17/08/21	MT
Sector Update: Health Care Stocks Rising Tuesday, Resisting Downward Market Pull	17/08/21	MT
Sector Update: Health Care Stocks Flat To Lower Premarket Tuesday	17/08/21	MT
DJ Industrial : Wall Street Sees Downbeat Session, US Retail Sales Fall More Than Expected in July	17/08/21	MT
Update: Sema4 Q2 Net Loss Widens Despite Revenue Boost -- Shares Slump in Pre-Market	17/08/21	MT
SEM4 HLDG : Sema4 Q2 Net Loss Widens Despite Revenue Boost	16/08/21	MT
SEM4 HLDG : Earnings Flash (SMFR) SEMA4 Posts Q2 Revenue $46.9M	16/08/21	MT
CM Life Sciences III : Agree to Business Combination; Shares Rise Early	06/08/21	MT
Sema4 Closes Transaction with CM Life Sciences, Debuts as Publicly Traded AI-driven Genomic & Clinical Data Platform Company	22/07/21	CI
CM Life Sciences, Inc.(NasdaqCM:CMLF) dropped from NASDAQ Composite Index	22/07/21	CI
Mount Sinai Genomics, Inc. completed the acquisition of CM Life Sciences, Inc. from CMLS Holdings LLC, Eli D. Casdin, Keith A. Meister and others in a reverse merger transaction.	21/07/21	CI
Cm Life Sciences, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21/07/21	CI
Cm Life Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	24/05/21	CI
CM Life Sciences III Raises $552 Million in IPO	09/04/21	MT
Cm Life Sciences, Inc. Reports Earnings Results for the Half Year Ended December 31, 2020	30/03/21	CI
CM Life Sciences II : SomaLogic to Go Public Through Combination With SPAC	29/03/21	MT
CM Life Sciences : SomaLogic to merge with Keith Meister-backed SPAC in $1.23 bln deal	29/03/21	RE
CM Life Sciences : SomaLogic to go public through SPAC merger in $1.23 bln deal	29/03/21	RE
Market Chatter: CM Life Sciences II Reportedly Nears $1.25 Billion SPAC Merger Deal With SomaLogic	29/03/21	MT
SPAC trading pops deflate as 'exuberance and greed' depart	25/03/21	RE
CM Life Sciences II : REFILE-UPDATE 1-SPAC trading pops deflate as 'exuberance and greed' depart	24/03/21	RE
Certain Class B Common Stock of CM Life Sciences, Inc. are subject to a Lock-Up Agreement Ending on 1-MAR-2021.	28/02/21	CI

Chart SEM4 HLDG

Duration

Period

More charts

Company Profile

Sema4 Holdings Corp, formerly CM Life Sciences Inc., is a patient-centered health intelligence company, which is focused on advancing healthcare through data-driven insights. The Company applies artificial intelligence (AI) and machine learning to clinical and genomic data to build models of human health and defining individualized health trajectories. The Company's health intelligence platform, Centrellis enables users to generate complete understanding of disease and wellness and to provide science-driven solutions to the pressing medical needs. Its products include Noninvasive Prenatal Select, Expanded Carrier Screen, Natalis Newborn Screen and Sema4 Signal Oncology Solutions. Noninvasive Prenatal Select is a blood test for insight into the user's baby health from nine weeks into pregnancy. Expanded Carrier Screen is a carrier screen for inherited conditions. Natalis Newborn Screen is a home test that provides insight into user's baby health by screening childhood diseases.

Sector

Investment Holding Companies

More about the company

Sector Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+111.71%	6.55B
APPLE ISPORTS GROUP, INC.	+98.02%	1.23B
CHURCHILL CAPITAL CORP VII	+2.52%	986M
PERELLA WEINBERG PARTNERS	+14.96%	752M
ARES ACQUISITION CORPORATION II	+2.11%	666M
E7 GROUP	+2.33%	620M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+8.61%	528M
CAPITOL INVESTMENT CORP. VII	-.--%	500M

Shell Companies